Sigma-Aldrich names Patrick Sullivan new VP of research and development for research biotech
Advertisement
Sigma-Aldrich announced that Patrick M. Sullivan has been named the Vice President of R&D for the Research Biotech business unit, effective October 1, 2007. In this role, he will help expand Sigma-Aldrich's position through the development of new and innovative products for life science researchers. Sullivan has been involved with Sigma-Aldrich since 2005 as a member of the Company's Scientific Advisory Board, where he provided a large pharmaceutical perspective on new strategic plans and product offerings in the Company's Research Biotech business unit. Sullivan will report directly to David A. Smoller, Ph.D., President of Research Biotech.